# Translational Genomics and Precision Medicine in Cancer Training Program

> **NIH NIH T32** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2024 · $421,294

## Abstract

PROJECT SUMMARY
There is a critical need to train the next generation of translational cancer researchers in light of a new era of
genomic medicine and big data. We must ensure that scientists are trained in the areas of highest need for
translation of data and experiments into clinical practice. This application proposes renewal of the Translational
Genomics and Precision Medicine Approaches in Cancer (TGP) training program developed at MD
Anderson Cancer Center, where we have a single mission to eliminate cancer, in order to expand and enhance
the training of outstanding predoctoral and postdoctoral fellows using an innovative curriculum and
multidisciplinary approach centered on core competencies in state-of-the-art areas of translational research.
Objectives: 1) to provide a comprehensive program with both depth and breadth in areas important to the future
of translational cancer research including translational genomics and precision medicine approaches, early
detection and prognosis of cancer, as well as diagnostic applications; 2) to recruit top predoctoral and
postdoctoral fellows interested in a career in translational cancer research in this area; 3) to provide fellows with
an inclusive, innovative environment, and with the infrastructure, faculty and administrative support to allow them
to make significant contributions to the field and further the mission of the MD Anderson Cancer Center.
Rationale: The TGP Training Program will provide the necessary education and training as well as
infrastructure and oversight to develop innovative, big data genome scientists. A highly competitive selection
process will identify outstanding candidates and ensure diversity in the process. Qualified candidates, in addition
to a mentored research experience by one of our outstanding training grant faculty, will gain individualized,
interdisciplinary training in core competency areas critical to the future of translational science in a post-genome
world.
Design of T32 Program: The T32 will offer 3 postdoctoral and 3 predoctoral fellowships designed around core
competencies which include: 1) translational cancer research, to gain exposure to mechanistic studies in
translational research and their importance to the human organism; 2) precision medicine to gain experience in
state-of-the-art approaches to diagnose and treat cancer patients; 3) translational genetics and genomics to gain
competency in understanding and implementation of cancer precision medicine; 4) bioinformatics, to learn how
to read and interpret large datasets; and 5) exposure to clinical grand rounds, tumor boards, and industrial
collaborations. Key activities include: state-of-the-art curriculum, tumor boards, exposure to NCI clinical trials
network and MD Anderson strategic alliances between academia and industry, and focused, inclusive mentoring.
All trainees will be required to have strong interest in cancer research and for postdoctorates, experience in
cancer research. Training d...

## Key facts

- **NIH application ID:** 10848855
- **Project number:** 2T32CA217789-06A1
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** Subrata Sen
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $421,294
- **Award type:** 2
- **Project period:** 2018-04-01 → 2029-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10848855

## Citation

> US National Institutes of Health, RePORTER application 10848855, Translational Genomics and Precision Medicine in Cancer Training Program (2T32CA217789-06A1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10848855. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*